ebag418.con
It wouldn’t be Christmas without a bit of Michael Buble, and in Denia that honour goes to Luis Manuel Gil who will be performing his tribute act for a very extraordinary charity event. With the title, ‘Music to Help’ it has been organised by the Fila Alkamar in order to raise funds for those affected by the recent DANA. Fans of Michael Buble can look forward to hearing some of his biggest hits, including “Feeling Good,” “Haven’t Met You Yet,” and “Home.” There will likely be one or two Christmas classics included as well, helping attendees get into the holiday spirit. This wondrous evening will take place at the Auditorium Theatre of the Denia Social Centre on Friday December 13, with a start time of 8.30pm. Most Read on Euro Weekly News Journey to Bethlehem: Valencia Fundraiser Jalon Valley Help Christmas Market Condado Club secures spot on ‘Best nightclubs in the World’ Those unable to attend Music to Help can still donate For those who would like to contribute to the cause but are unable to attend, this is still possible through the ‘Row 0’ scheme that the organisers have put in place. Donations collected via Row 0 will be used in full for fundraising. In addition, a percentage of the ticket sales will also be passed on to the cause. For added security and transparency, all funds raised will be managed through @adoptauncomercio_ solidarity platform. Tickets for this wonderful concert cost €20 and are available via WhatsApp only by contacting 626 808 271. Find more local news, activities and profile interviews for Costa Blanca North.Investors often hold blue-chip stocks at the core of their portfolios. That makes sense. After all, blue-chip companies are leaders in their industries. Their names are familiar to investors. Blue-chip stocks are from companies that are large, well-established, and financially sound. These companies have strong brand names and reputations, and they generate dependable earnings. Blue-chip companies usually boast consistent dividends and are often considered to be less risky, given their financial stability. However, investors may differ in how they define blue-chip companies. Some investors demand that a blue-chip stock be included in a particular index, such as the Dow Jones Industrial Average. Others may only include dividend-paying companies on their lists of blue-chip stocks. Still others may have specific market-capitalization thresholds for blue-chip companies. The companies on Morningstar's list of the best blue-chip stocks to buy for the long term share a few qualities: • The stocks are from companies included on Morningstar's list of the Best Companies to Own for 2024. Companies on this list have wide Morningstar Economic Moat Ratings and predictable cash flows, and they are run by management teams that make smart capital allocation decisions. • These stocks look undervalued, which means they're trading below Morningstar's fair value estimates. • Their market caps top $100 billion. 10 Best Blue-Chip Stocks to Buy for the Long Term—December 2024 These are the largest firms by market cap on Morningstar's Best Companies to Own list whose stocks were at least 15% undervalued as of Dec. 16, 2024. 1 - Anheuser-Busch InBev BUD 2 - Pfizer PFE 3 - Roche RHHBY 4 - Nike NKE 5 - Nestle NSRGY 6 - Sanofi SNY 7 - Danaher DHR 8 - Merck MRK 9 - Thermo Fisher Scientific TMO 10 - Bristol-Myers Squibb BMY Here's a little bit about each of these blue-chip stocks for the long term. Data is as of Dec. 16. Anheuser-Busch InBev • Market Capitalization: $105... Margaret Giles
An animal-rescue pilot died in a crash. 2 dogs aboard are recovering
LG Energy Solution, Qualcomm To Boost Chip-Based Battery Management
Older adults in the U.S. skip needed medical care at much higher rates compared to other developed countries, according recent survey conducted by The Commonwealth Fund . The study said 8% to 9% of older Americans skip necessary treatment compared to just 2% of seniors in countries like Sweden, the Netherlands, the U.K. and Germany. The survey said nearly all Americans aged 65 or older are covered by Medicare and have access to most basic health services. Yet they pay more for health care and are more likely to postpone or skip needed care because of the cost. RELATED STORY | Medicare enrollment is complicated, but saving money doesn't have to be Nearly a quarter of older adults in the U.S. spent at least $2,000 over the past year on out-of-pocket expenses, compared to less than 5% in France and the Netherlands who spent the same amount, the survey said. The survey results are similar for dental and mental health care, The Commonwealth Fund said. One in five older adults in the U.S., Australia and Canada reported skipping needed dental care, compared to 5% or less of older adults in the Netherlands and Germany. The survey said less than 5% of older adults in all countries reported skipping mental health services over the past year because of the cost. RELATED STORY | Medicare premiums will rise yet again in 2025. Here's what you need to know
Researchers have developed a new tool that will help scientists study how genes are expressed in our cells. The tool, called SigRM, is used to analyze data from single-cell epitranscriptomics, a method for studying RNA modifications in individual cells. This research could lead to important insights into health and disease. Recent advances in single-cell technology have enabled researchers to analyse thousands of individual cells at once, providing rich information about the expression and activity of genes and proteins, as well as chemical changes that affect gene expression. A major tool in these studies is single-cell epitranscriptomics, which studies RNA modifications like m6A methylation, which can significantly influence gene regulation and are important in various diseases. RNA methylation is a chemical change that attaches a small marker molecule to RNA molecules. This change is crucial in many cell processes, including gene regulation and overall cell behavior. SigRM, which was published in the journal Cell Genomics , can be used to build condition-specific regulatory networks from the data, helping researchers map how RNA methylation is controlled in different situations. With single-cell epitranscriptomics tools, researchers can focus specifically on RNA modifications in individual cells, enabling them to study the variation between different cells. However, existing techniques for analysing this data are still quite basic, and many important questions about RNA methylation and its variability across different cells remain open. The SigRM framework addresses these challenges effectively, providing improved detection and quantification of RNA methylation sites,." Professor Jia Meng, Head of the Department of Biological Sciences at Xi'an Jiaotong–Liverpool University (XJTLU) and lead researcher of the study By analysing single-cell epitranscriptomic data, researchers can track how RNA modifications happen across different cell groups. SigRM not only helps construct regulatory networks based on this data but also tracks how cells change states over time, a process known as trajectory inference. The results from SigRM have been validated against existing biological knowledge, demonstrating its reliability. The new tool will be invaluable in understanding complex regulatory mechanisms, especially in diseases like cancer. "The implications of SigRM reach far beyond the lab. Its development represents a significant advance in our understanding of how RNA modifications influence gene regulation," says Professor Meng. "Our work not only addresses critical gaps in analysis techniques but also provides valuable insights that could pave the way for breakthroughs in medical research and biotechnology, enhancing our understanding of how RNA modifications impact health and disease." Xi'an Jiaotong–Liverpool University (XJTLU) Wang, H., et al. (2024). Statistical modeling of single-cell epitranscriptomics enabled trajectory and regulatory inference of RNA methylation. Cell Genomics . doi.org/10.1016/j.xgen.2024.100702 .Daiwa Securities Group Inc. boosted its stake in shares of GlobalFoundries Inc. ( NASDAQ:GFS – Free Report ) by 11.9% in the 3rd quarter, Holdings Channel.com reports. The firm owned 35,292 shares of the company’s stock after buying an additional 3,744 shares during the quarter. Daiwa Securities Group Inc.’s holdings in GlobalFoundries were worth $1,421,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Several other large investors have also recently bought and sold shares of the stock. DekaBank Deutsche Girozentrale raised its stake in GlobalFoundries by 4.0% during the 3rd quarter. DekaBank Deutsche Girozentrale now owns 8,773 shares of the company’s stock valued at $357,000 after purchasing an additional 340 shares during the last quarter. CWM LLC raised its stake in GlobalFoundries by 38.6% during the 2nd quarter. CWM LLC now owns 1,339 shares of the company’s stock valued at $68,000 after purchasing an additional 373 shares during the last quarter. Pacer Advisors Inc. raised its stake in GlobalFoundries by 1.7% during the 2nd quarter. Pacer Advisors Inc. now owns 26,359 shares of the company’s stock valued at $1,333,000 after purchasing an additional 444 shares during the last quarter. Royal London Asset Management Ltd. raised its stake in shares of GlobalFoundries by 1.3% in the 2nd quarter. Royal London Asset Management Ltd. now owns 34,765 shares of the company’s stock valued at $1,758,000 after buying an additional 450 shares in the last quarter. Finally, Advisors Asset Management Inc. raised its stake in shares of GlobalFoundries by 41.0% in the 3rd quarter. Advisors Asset Management Inc. now owns 1,593 shares of the company’s stock valued at $64,000 after buying an additional 463 shares in the last quarter. GlobalFoundries Stock Up 0.9 % Shares of NASDAQ:GFS opened at $43.25 on Friday. GlobalFoundries Inc. has a 12 month low of $35.85 and a 12 month high of $62.61. The company’s 50-day moving average price is $40.86 and its two-hundred day moving average price is $45.80. The company has a quick ratio of 1.76, a current ratio of 2.42 and a debt-to-equity ratio of 0.19. The firm has a market cap of $23.86 billion, a P/E ratio of 32.28, a P/E/G ratio of 10.46 and a beta of 1.53. Wall Street Analysts Forecast Growth A number of brokerages have recently issued reports on GFS. Susquehanna dropped their price objective on shares of GlobalFoundries from $50.00 to $48.00 and set a “neutral” rating for the company in a research note on Wednesday, November 6th. Robert W. Baird dropped their price objective on shares of GlobalFoundries from $63.00 to $50.00 and set an “outperform” rating for the company in a research note on Wednesday, November 6th. Needham & Company LLC restated a “hold” rating on shares of GlobalFoundries in a research note on Wednesday, November 6th. Morgan Stanley cut shares of GlobalFoundries from an “overweight” rating to an “equal weight” rating and dropped their price objective for the company from $53.00 to $43.00 in a research note on Monday, October 28th. Finally, Cantor Fitzgerald restated a “neutral” rating and issued a $40.00 price objective on shares of GlobalFoundries in a research note on Wednesday, November 6th. Nine investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $50.21. View Our Latest Stock Analysis on GlobalFoundries GlobalFoundries Profile ( Free Report ) GlobalFoundries Inc, a semiconductor foundry, provides range of mainstream wafer fabrication services and technologies worldwide. It manufactures various semiconductor devices, including microprocessors, mobile application processors, baseband processors, network processors, radio frequency modems, microcontrollers, and power management units. Featured Stories Want to see what other hedge funds are holding GFS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GlobalFoundries Inc. ( NASDAQ:GFS – Free Report ). Receive News & Ratings for GlobalFoundries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlobalFoundries and related companies with MarketBeat.com's FREE daily email newsletter .The Buffalo Bills (9-2) are slated to face the San Francisco 49ers (5-6) on "Sunday Night Football" amid an in the Buffalo metro area this weekend. Leading up to kickoff, Bills quarterback Josh Allen made waves on social media on Friday after to actress Hailee Steinfeld. Javascript is required for you to be able to read premium content. Thanks for the feedback.
Tim Keating Joins AMD as Senior Vice President, Government Relations and Regulatory AffairsThe Latest: Police believe gunman who killed UnitedHealthcare CEO has left New York CityDomenico Ferrera
Fluence Energy, Inc. Announces Convertible Notes Offering and Intention to Enter into Capped Call Transactions
Erik Pratt scores 20 as Milwaukee defeats North Central College 92-57No secrets as Bucs visit Dave Canales, Panthers for NFC South showdown
Ocean acidification is reaching deeper watersCharles Schwab Investment Management Inc. boosted its stake in shares of Select Medical Holdings Co. ( NYSE:SEM – Free Report ) by 1.5% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,646,320 shares of the health services provider’s stock after purchasing an additional 24,439 shares during the period. Charles Schwab Investment Management Inc.’s holdings in Select Medical were worth $57,407,000 at the end of the most recent quarter. A number of other institutional investors and hedge funds have also bought and sold shares of the business. GAMMA Investing LLC raised its holdings in Select Medical by 16.6% during the third quarter. GAMMA Investing LLC now owns 2,313 shares of the health services provider’s stock valued at $81,000 after acquiring an additional 330 shares during the period. Foster & Motley Inc. raised its holdings in Select Medical by 3.1% during the second quarter. Foster & Motley Inc. now owns 12,147 shares of the health services provider’s stock valued at $426,000 after acquiring an additional 370 shares during the period. KBC Group NV raised its holdings in Select Medical by 4.5% during the third quarter. KBC Group NV now owns 13,050 shares of the health services provider’s stock valued at $455,000 after acquiring an additional 563 shares during the period. Arizona State Retirement System raised its holdings in Select Medical by 2.0% during the second quarter. Arizona State Retirement System now owns 30,544 shares of the health services provider’s stock valued at $1,071,000 after acquiring an additional 593 shares during the period. Finally, Hexagon Capital Partners LLC raised its holdings in Select Medical by 528.7% during the second quarter. Hexagon Capital Partners LLC now owns 767 shares of the health services provider’s stock valued at $27,000 after acquiring an additional 645 shares during the period. 89.48% of the stock is owned by institutional investors. Insider Buying and Selling In other Select Medical news, Director Marilyn B. Tavenner sold 32,000 shares of the business’s stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total transaction of $674,880.00. Following the completion of the transaction, the director now owns 22,000 shares in the company, valued at $463,980. The trade was a 59.26 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link . 19.14% of the stock is currently owned by company insiders. Analysts Set New Price Targets Get Our Latest Report on Select Medical Select Medical Trading Up 3.7 % SEM opened at $21.11 on Friday. The firm has a market cap of $2.73 billion, a P/E ratio of 9.86, a P/E/G ratio of 0.91 and a beta of 1.42. Select Medical Holdings Co. has a 12 month low of $20.00 and a 12 month high of $40.98. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37. The stock has a 50-day moving average of $34.11 and a 200 day moving average of $34.71. Select Medical ( NYSE:SEM – Get Free Report ) last released its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 EPS for the quarter, topping the consensus estimate of $0.36 by $0.07. The company had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.74 billion. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The firm’s revenue was up 5.7% on a year-over-year basis. During the same quarter last year, the business posted $0.46 earnings per share. As a group, research analysts forecast that Select Medical Holdings Co. will post 2.16 EPS for the current year. Select Medical Announces Dividend The business also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Wednesday, November 13th were given a $0.125 dividend. The ex-dividend date of this dividend was Wednesday, November 13th. This represents a $0.50 annualized dividend and a yield of 2.37%. Select Medical’s dividend payout ratio is currently 23.36%. Select Medical Company Profile ( Free Report ) Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra. Recommended Stories Want to see what other hedge funds are holding SEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Select Medical Holdings Co. ( NYSE:SEM – Free Report ). Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter .( MENAFN - Gulf Times) Groundbreaking weight-loss drugs like Ozempic and Wegovy have understandably generated a lot of excitement, bringing hope to the hundreds of millions of people grappling with obesity. When combined with a healthier diet and exercise, these drugs, which work by suppressing appetite, deliver an average 10% reduction in body weight that can be sustained for years. With more than two-thirds of adults in the United Kingdom and nearly three-quarters in the US classified as overweight or obese – a health crisis that costs national economies billions of dollars annually – physicians and policymakers could be forgiven for embracing these drugs as a panacea. US President Joe Biden's administration, for example, recently proposed requiring Medicare and Medicaid to cover the costs of weight-loss drugs, offering access to millions of Americans. But addressing obesity requires much more than a technological fix. To be clear, I am not suggesting these drugs are unnecessary or that medical professionals should avoid prescribing them. But they do not address the problem fuelling the global obesity crisis (and contributing to the climate crisis as well): our broken food system. The alarming rise in obesity over the past 30 years is not simply a byproduct of higher living standards or more sedentary lifestyles, though these factors play a pivotal role. The primary factor appears to be the transformation of our food environment, which has fundamentally altered both the types of food we consume and our eating habits. In recent years, scientists and health experts have increasingly focused on the high-fat, sugar, and salt (HFSS) foods driving unhealthy dietary habits. This trend can be attributed to companies reshaping the food system to produce ultra-processed, hyper-palatable, and highly profitable foods. Consequently, people are snacking more, eating larger portions, and preparing fewer meals themselves. In the UK, for example, the snack market has boomed while the time spent preparing meals has sharply declined. These changes haven't just fuelled the rapid increase in HFSS food consumption. They have also led to a surge in meat consumption, especially in Europe and North America, where meat-heavy diets have become all too common. Beyond the heightened risk of heart disease and related health conditions, excessive meat consumption has had devastating effects on the climate and biodiversity. Research shows that animal-based foods generate twice the greenhouse-gas (GHG) emissions of plant-based alternatives. Just as health experts urge us to reduce our HFSS intake, climate scientists consistently emphasize the importance of cutting meat and dairy consumption to keep global warming within safe limits. In an effort to prevent a lasting change in people's eating habits, the meat industry is seeking techno-fixes to cut GHG emissions. For example, funding for research on cutting farm emissions – such as feed additives designed to reduce methane levels in cows' burps – has increased markedly. Such solutions are particularly attractive to governments reluctant to introduce measures that influence consumer behaviour. Fearful of opposition from the Big Food lobby and wary of accusations of overreach, policies like sugar taxes or meat taxes are deemed political hot potatoes to be avoided at all costs. But the overlapping crises our broken food system is fuelling – from the billions of dollars spent each year on diet-related health problems to the environmental degradation pushing our planet to its limits – cannot be wished away or fixed with technological band-aids. Instead, what is needed is a major shift in dietary habits toward foods that nourish both people and the environment. To this end, the EAT-Lancet Commission – comprised of the world's leading nutrition and sustainability experts – advocates a diet rich in fresh fruits and vegetables, whole grains, and plant-based proteins while reducing consumption of animal proteins, dairy, and sugars. Taken together, these recommendations offer a clear blueprint for ensuring health and sustainability. Admittedly, it is unrealistic to expect consumers – conditioned by food environments designed for profit rather than human or environmental health – to drive this transition on their own. With unhealthy foods widely available and aggressively marketed, many consumers often struggle to moderate their food intake and, in some cases, develop addictive behaviours. Governments and food manufacturers must take proactive measures to reshape these environments, such as expanding initiatives aimed at reducing the consumption of HFSS foods to include meat, thereby encouraging people to eat more plant-based whole foods and meat alternatives. Another potential solution would be to extend bans on promotional deals for unhealthy foods to cover meat products. Requiring food companies to report on the types of food they sell, including HFSS foods and the ratio of plant-based to animal proteins, would also help. These measures would incentivise businesses to prioritise healthier, more sustainable options over less nutritious ones. None of this is to suggest that the new generation of weight-loss drugs cannot benefit individuals living with obesity. For those trapped in a cycle of poor health, Ozempic and Wegovy could even save lives, and efforts to make these treatments widely available are a welcome step. But it is essential that we recognise that this approach treats the symptoms rather than the underlying pathology. Defusing the time bombs of ill health and environmental catastrophe requires fast, decisive action to remake our dysfunctional food system. – Project Syndicate lEmily Armistead is Interim Executive Director of Madre Brava. MENAFN22122024000067011011ID1109022142 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
NATO Ukraine to hold emergency talks after Russia's attack with new hypersonic missileIowa QB Cade McNamara slams 'ridiculous' rumors
Blue Ocean Acquisition Stock Hits All-Time High at $12.5A bid by The Onion satirical news outlet to buy Alex Jones’ conspiracy theory platform Infowars returned Monday to a Texas courtroom, where a judge heard arguments on whether a was properly run as Jones alleges collusion and fraud. U.S. Bankruptcy Judge Christopher Lopez in Houston is looking into the November auction and how a trustee chose The Onion over the only other bidder — a company affiliated with Jones that offered twice as much money as The Onion. The judge said the hearing would last into Monday evening and pick up again on Tuesday afternoon. Lopez is the same judge handling the Steward Health Care bankruptcy that involves whether Sharon Regional Medical Center in Sharon will change ownership or be closed. The sale of Infowars is part of , which he filed in late 2022 after he was ordered to pay in defamation lawsuits in Connecticut and Texas filed by relatives of victims of the Sandy Hook Elementary School shooting in Connecticut. Jones repeatedly called the 2012 shooting that killed 20 children and six educators a hoax staged by actors and aimed at increasing gun control. Most of the proceeds from the sale of Infowars, as well as many of Jones’ personal assets, will go to the Sandy Hook families to help satisfy judgments issued by juries and judges in state courts in Connecticut and Texas. Some proceeds will go to Jones’ other creditors. The Onion, which wants to turn Infowars’ website and social media accounts into , offered $1.75 million for Infowars’ assets in the auction, while First United American Companies — which runs a website in Jones’ name that sells nutritional supplements — bid $3.5 million. The Onion’s bid also included a pledge by many of the Sandy Hook families to forgo some or all of the auction proceeds due to them to give other creditors a total of $100,000 more than they would receive under other bids. The trustee, Christopher Murray, chose The Onion, saying its proposal was better for creditors because they would receive more money. Joshua Wolfshohl, an attorney for Murray, told the judge Monday that no wrongdoing occurred during the auction. He called the complaints by Jones and First United American Companies unfounded. “The vast majority of their complaints are just fantastic, imagined conspiracy theories that have no basis in reality,” he said. Jones’ lawyer, Ben Broocks, questioned Murray’s rationale for choosing The Onion and alleged that a recent deposition of the trustee showed improprieties. He also questioned the validity of The Onion’s bid, saying it was technically valued at $7 million because of the incentive offered by the Sandy Hook families. An auction company executive involved in the sale testified most of the afternoon. In court filings, Jones and First United American Companies of illegally colluding on the bidding, committing fraud and violating the judge’s rules for the auction. Murray, The Onion and the families deny the allegations. In his own court filing, Murray called the allegations “a disappointed bidder’s improper attempt to influence an otherwise fair and open auction process.” Up for sale at the auction were all the equipment and other assets in the Infowars studio in Austin, Texas, as well as its social media accounts, websites, video archive and product trademarks. Jones uses the studio to broadcast his far-right, conspiracy theory-filled shows on the Infowars website, his account on the social platform X and radio stations. Jones has set up another studio, websites and social media accounts in case The Onion wins approval to buy Infowars and kicks him out. Jones has said he could continue using the Infowars platforms if the auction winner is friendly to him.
Citigroup Inc. trimmed its holdings in Assurant, Inc. ( NYSE:AIZ – Free Report ) by 9.5% in the third quarter, HoldingsChannel reports. The fund owned 51,364 shares of the financial services provider’s stock after selling 5,375 shares during the period. Citigroup Inc.’s holdings in Assurant were worth $10,214,000 at the end of the most recent quarter. Other hedge funds have also recently made changes to their positions in the company. AQR Capital Management LLC boosted its holdings in Assurant by 32.5% during the 2nd quarter. AQR Capital Management LLC now owns 1,041,678 shares of the financial services provider’s stock valued at $173,179,000 after acquiring an additional 255,471 shares during the period. Dimensional Fund Advisors LP grew its holdings in shares of Assurant by 1.9% in the second quarter. Dimensional Fund Advisors LP now owns 698,677 shares of the financial services provider’s stock worth $116,159,000 after purchasing an additional 12,935 shares during the last quarter. TD Asset Management Inc increased its stake in shares of Assurant by 20.4% in the second quarter. TD Asset Management Inc now owns 566,123 shares of the financial services provider’s stock worth $94,118,000 after buying an additional 96,021 shares during the period. Mizuho Securities USA LLC raised its holdings in Assurant by 11,480.4% during the 3rd quarter. Mizuho Securities USA LLC now owns 464,952 shares of the financial services provider’s stock valued at $92,460,000 after buying an additional 460,937 shares during the last quarter. Finally, Federated Hermes Inc. boosted its position in Assurant by 0.7% during the 2nd quarter. Federated Hermes Inc. now owns 383,549 shares of the financial services provider’s stock valued at $63,765,000 after buying an additional 2,700 shares during the period. 92.65% of the stock is currently owned by institutional investors. Assurant Trading Up 0.0 % Shares of AIZ opened at $227.10 on Friday. The firm’s 50-day moving average price is $203.46 and its 200-day moving average price is $186.07. The firm has a market capitalization of $11.65 billion, a price-to-earnings ratio of 16.20 and a beta of 0.57. The company has a current ratio of 0.42, a quick ratio of 0.42 and a debt-to-equity ratio of 0.40. Assurant, Inc. has a 1-year low of $160.12 and a 1-year high of $230.55. Assurant Increases Dividend The firm also recently declared a quarterly dividend, which will be paid on Monday, December 30th. Investors of record on Monday, December 9th will be given a dividend of $0.80 per share. This is a boost from Assurant’s previous quarterly dividend of $0.72. This represents a $3.20 dividend on an annualized basis and a yield of 1.41%. The ex-dividend date is Monday, December 9th. Assurant’s dividend payout ratio (DPR) is 22.82%. Wall Street Analyst Weigh In Several equities analysts have recently commented on AIZ shares. Keefe, Bruyette & Woods upped their price objective on shares of Assurant from $194.00 to $212.00 and gave the company a “market perform” rating in a research note on Tuesday, November 12th. Piper Sandler increased their price objective on Assurant from $200.00 to $217.00 and gave the stock a “neutral” rating in a report on Wednesday, October 2nd. UBS Group boosted their target price on Assurant from $217.00 to $224.00 and gave the company a “buy” rating in a research note on Monday, September 23rd. StockNews.com lowered Assurant from a “buy” rating to a “hold” rating in a research note on Thursday, October 17th. Finally, Bank of America boosted their price objective on shares of Assurant from $228.00 to $233.00 and gave the company a “buy” rating in a research report on Thursday, October 10th. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $225.20. View Our Latest Analysis on AIZ Insider Activity at Assurant In related news, EVP Biju Nair sold 3,000 shares of Assurant stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $209.18, for a total transaction of $627,540.00. Following the completion of the transaction, the executive vice president now directly owns 20,658 shares of the company’s stock, valued at $4,321,240.44. This trade represents a 12.68 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink . 0.53% of the stock is currently owned by corporate insiders. Assurant Company Profile ( Free Report ) Assurant, Inc, together with its subsidiaries, provides business services that supports, protects, and connects consumer purchases in North America, Latin America, Europe, and the Asia Pacific. The company operates through two segments: Global Lifestyle and Global Housing. The Global Lifestyle segment offers mobile device solutions, and extended service contracts and related services for consumer electronics and appliances, and credit and other insurance products; and vehicle protection, commercial equipment, and other related services. Featured Articles Want to see what other hedge funds are holding AIZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Assurant, Inc. ( NYSE:AIZ – Free Report ). Receive News & Ratings for Assurant Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assurant and related companies with MarketBeat.com's FREE daily email newsletter .Nvidia stock slides as China opens antitrust probe against AI chip heavyweightTrump taps forceful ally of hard-line immigration policies to head Customs and Border Protection
Top 5 Ways to Bypass Internet ShutdownsTrump taps forceful ally of hard-line immigration policies to head Customs and Border Protection
Dave Portnoy weighs in on Michigan vs. Ohio State brawl as cops use pepper sprayChiefs' DeAndre Hopkins Seeking Therapy After Dropped PassThe Fortnite Remix: The Finale live event is a major concert experience happening in-game. This event showcases global artists, exclusive tracks and special in-game rewards for participants. Start Date and Time The Fortnite Remix: The Finale concert starts on Saturday, November 30, at 2 PM ET. Here is the timing for various regions: Also Read : Biggest question: As Trump takes over as the 47th U.S President, what will his salary be? Here is a breakdown Los Angeles: 11 AM PT Mexico City: 1 PM CST Finance Financial Literacy for Non-Finance Executives By - CA Raja, Chartered Accountant | Financial Management Educator | Former AVP - Credit, SBI View Program Artificial Intelligence(AI) Tabnine AI Masterclass: Optimize Your Coding Efficiency By - Metla Sudha Sekhar, IT Specialist and Developer View Program Web Development Advanced C++ Mastery: OOPs and Template Techniques By - Metla Sudha Sekhar, IT Specialist and Developer View Program Office Productivity Zero to Hero in Microsoft Excel: Complete Excel guide 2024 By - Metla Sudha Sekhar, IT Specialist and Developer View Program Finance AI and Generative AI for Finance By - Hariom Tatsat, Vice President- Quantitative Analytics at Barclays View Program Artificial Intelligence(AI) Master in Python Language Quickly Using the ChatGPT Open AI By - Metla Sudha Sekhar, IT Specialist and Developer View Program Strategy Succession Planning Masterclass By - Nigel Penny, Global Strategy Advisor: NSP Strategy Facilitation Ltd. View Program Marketing Future of Marketing & Branding Masterclass By - Dr. David Aaker, Professor Emeritus at the Haas School of Business, UC Berkeley, Author | Speaker | Thought Leader | Branding Consultant View Program Artificial Intelligence(AI) Basics of Generative AI: Unveiling Tomorrow's Innovations By - Metla Sudha Sekhar, IT Specialist and Developer View Program Finance A2Z Of Money By - elearnmarkets, Financial Education by StockEdge View Program Marketing Digital Marketing Masterclass by Pam Moore By - Pam Moore, Digital Transformation and Social Media Expert View Program Office Productivity Mastering Google Sheets: Unleash the Power of Excel and Advance Analysis By - Metla Sudha Sekhar, IT Specialist and Developer View Program Data Science SQL Server Bootcamp 2024: Transform from Beginner to Pro By - Metla Sudha Sekhar, IT Specialist and Developer View Program Office Productivity Microsoft Word Mastery: From Beginner to Expert By - CA Raj K Agrawal, Chartered Accountant View Program Leadership Business Storytelling Masterclass By - Ameen Haque, Founder of Storywallahs View Program Artificial Intelligence(AI) AI-Powered Python Mastery with Tabnine: Boost Your Coding Skills By - Metla Sudha Sekhar, IT Specialist and Developer View Program Artificial Intelligence(AI) AI and Analytics based Business Strategy By - Tanusree De, Managing Director- Accenture Technology Lead, Trustworthy AI Center of Excellence: ATCI View Program Artificial Intelligence(AI) Java Programming with ChatGPT: Learn using Generative AI By - Metla Sudha Sekhar, IT Specialist and Developer View Program Web Development C++ Fundamentals for Absolute Beginners By - Metla Sudha Sekhar, IT Specialist and Developer View Program Leadership Boosting Startup Revenue with 6 AI-Powered Sales Automation Techniques By - Dr. Anu Khanchandani, Startup Coach with more than 25 years of experience View Program Marketing Modern Marketing Masterclass by Seth Godin By - Seth Godin, Former dot com Business Executive and Best Selling Author View Program New York: 2 PM ET São Paulo: 4 PM BRT London: 7 PM GMT Paris: 8 PM CET Riyadh: 10 PM AST Seoul: 4 AM KST (December 1) Tokyo: 4 AM JST (December 1) Sydney: 6 AM AEDT (December 1) Auckland: 8 AM NZDT (December 1) Featured Artists The concert will feature music from Eminem, Ice Spice, Snoop Dogg and Juice WRLD. Highlights include: Snoop Dogg’s single, “Another Part of Me (feat. Sting)” A new track from Juice WRLD titled “Empty Out Your Pockets” Where to Watch To watch the event: Log into Fortnite before 2 PM ET on November 30. Navigate to the Homebar. Select the Remix: The Finale playlist in the Discover section. Juice WRLD’s Free Rewards Players who log in between November 25 and 10 PM ET on November 30 will receive: Also Read : Do Queen Camilla and Kate Middleton have a tense relationship? Her role in the monarchy may be re-evaluated when William becomes the king Slayer Juice WRLD Outfit 999 Knives Pickaxe and Back Bling Five exclusive loading screens, including one designed by Takashi Murakami FAQs What time does Fortnite Remix: The Finale start? The concert begins on November 30 at 2 PM ET, with global times adjusted for various regions. How can players get the Juice WRLD rewards for free? Log in between November 25 and November 30 to receive the Slayer Juice WRLD Outfit and related items the next day. (You can now subscribe to our Economic Times WhatsApp channel )Andrew Wiggins scores 30 to lead the Warriors past the Pelicans 112-108 in NBA Cup play
Vanguard International High Dividend Yield ETF (NASDAQ:VYMI) Shares Acquired by Citigroup Inc.Bitcoin ( BTC -0.13% ) continued to surge in value this year, maintaining its dominance as the largest and most valuable cryptocurrency on the planet. But looking ahead to 2025 and beyond, there's another cryptocurrency that could eventually rival Bitcoin's No. 1 position. That cryptocurrency, of course, is Ethereum ( ETH -0.18% ) , which also surged in value this year. Should you dump Bitcoin for Ethereum next year? You might be surprised by the answer. Bitcoin versus Ethereum in 2025 For those who don't know, there are a few major differences between Bitcoin and Ethereum. Bitcoin is primarily used as a store of value, like gold, but it can also be used for value exchange, like a traditional currency. Many projects are working to make Bitcoin more functional, including a handful of DeFi initiatives, but for the moment, those are its basic uses. Ethereum, on the other hand, was designed specifically to be flexible and extensible in order to serve as a foundation for other decentralized tools, services, and applications. That means Ethereum has far more potential uses than Bitcoin. But what about the differences in 2025? What's in store for these currencies? A host of Layer 2 projects are looking to make Ethereum faster, cheaper, and more efficient. New DeFi, non-fungible tokens, and gaming applications should also make the protocol more attractive to both users and developers. But there could also be some foundational improvements. Pending proposals include the adoption of new sharding improvements that can boost the protocol's ability to scale without limiting throughput or raising costs for transactions. Bitcoin already had a halving event in 2024, and the next is not expected until 2028. Layer 2 options like the Lightning Network, meanwhile, may improve Bitcoin's ability to act as a means of exchange, though Ethereum has more development effort aimed at solving this particular scaling issue. In general, Bitcoin's story remains a simple one. In 2025, expect more attention and adoption for Bitcoin from both retail and institutional investors, with new Bitcoin-based exchange-traded funds and investment options allowing more and more people to gain exposure to the cryptocurrency without needing to worry about special tax or custody challenges. With these differences in mind, which cryptocurrency is the superior investment for 2025? Bitcoin Price data by YCharts Which leading cryptocurrency is the better bet for 2025? While Bitcoin and Ethereum are often compared, they really have very different long-term use cases. While Bitcoin may gain more functionality over time, it should be viewed mainly as a store of value. Gold's current market cap is nearly $18 trillion, while Bitcoin's is still around $2 trillion. If you believe Bitcoin will be around for a while, there's clearly long-term upside potential as it closes the gap with gold. At its core, Ethereum is fundamentally different from other cryptocurrencies because it's not just a digital currency -- it's an entire technological platform. The smart contracts platform has already attracted the largest and most active developer community in the blockchain space, which gives it a significant competitive advantage. However, investing in Ethereum requires understanding that you're not just betting on a currency; you're investing in the potential of digital services using decentralized technology in the future. While this broader scope makes Ethereum more volatile than Bitcoin, it also creates more opportunities for substantial growth. Think of it as the difference between buying in digital gold (Bitcoin) and investing in the future of software infrastructure (Ethereum). Should you ditch Bitcoin for Ethereum in 2025? Only if you want to bet on the rise of decentralized networks. If you're undecided, however, you can always do what I did: buy some of both.